Genetic Variants and COVID-19 Severity
Author Information
Author(s): Mózner Orsolya, Szabó Edit, Kulin Anna, Várady György, Moldvay Judit, Vass Vivien, Szentesi Andrea, Jánosi Ágoston, Hegyi Péter, Sarkadi Balázs
Primary Institution: Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary
Hypothesis
Can specific genetic polymorphisms predict COVID-19 disease susceptibility and severity?
Conclusion
The study found that certain genetic variants are associated with increased susceptibility and severity of COVID-19 in hospitalized patients.
Supporting Evidence
- The study confirmed associations between COVID-19 severity and pre-existing diabetes.
- Higher allele frequencies of LZTFL1 and IFNAR2 variants correlated with greater COVID-19 susceptibility.
- Patients with a loss of smell or taste had less severe disease.
- Genetic polymorphisms may have predictive value for COVID-19 severity.
Takeaway
This study looked at how some people's genes might make them more likely to get really sick from COVID-19. They found that certain gene changes can help predict who might have a tougher time with the disease.
Methodology
The study analyzed genetic polymorphisms in 869 hospitalized COVID-19 patients and compared their allele frequencies to those in the general European population.
Potential Biases
Potential biases may arise from the absence of a control group and the reliance on existing genetic databases.
Limitations
The study lacked a large control group and did not perform population stratification due to limited data.
Participant Demographics
Among the 869 patients, 465 were male and 404 were female, with a mean age of 65 for severe cases and 61 for moderate cases.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website